wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26775383-47C63D32-7B7A-4409-89EA-87CD78218D34
Q26775383-47C63D32-7B7A-4409-89EA-87CD78218D34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775383-47C63D32-7B7A-4409-89EA-87CD78218D34
Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities
P2860
Q26775383-47C63D32-7B7A-4409-89EA-87CD78218D34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775383-47C63D32-7B7A-4409-89EA-87CD78218D34
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e8203df4cf941cc739cb9f897283ff8e9217ac21
P2860
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.